DekaBank Deutsche Girozentrale Sells 26,436 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

DekaBank Deutsche Girozentrale lowered its holdings in Henry Schein, Inc. (NASDAQ:HSIC) by 2.7% in the 1st quarter, according to the company in its most recent filing with the SEC. The firm owned 961,161 shares of the company’s stock after selling 26,436 shares during the quarter. DekaBank Deutsche Girozentrale owned approximately 0.75% of Henry Schein worth $71,888,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in HSIC. Arizona State Retirement System increased its position in Henry Schein by 0.4% during the 4th quarter. Arizona State Retirement System now owns 35,890 shares of the company’s stock valued at $2,717,000 after purchasing an additional 149 shares during the period. Empirical Finance LLC increased its position in shares of Henry Schein by 3.5% during the first quarter. Empirical Finance LLC now owns 4,764 shares of the company’s stock valued at $360,000 after buying an additional 160 shares during the period. Covestor Ltd raised its stake in Henry Schein by 12.8% in the first quarter. Covestor Ltd now owns 1,511 shares of the company’s stock worth $114,000 after buying an additional 171 shares in the last quarter. Keene & Associates Inc. lifted its holdings in Henry Schein by 4.0% in the first quarter. Keene & Associates Inc. now owns 4,505 shares of the company’s stock worth $340,000 after buying an additional 175 shares during the period. Finally, Wahed Invest LLC boosted its position in Henry Schein by 9.2% during the 4th quarter. Wahed Invest LLC now owns 2,222 shares of the company’s stock valued at $168,000 after acquiring an additional 187 shares in the last quarter. 96.62% of the stock is currently owned by institutional investors.

Henry Schein Stock Down 2.4 %

Shares of HSIC stock traded down $1.76 during mid-day trading on Friday, hitting $71.02. The company’s stock had a trading volume of 3,905,909 shares, compared to its average volume of 1,359,569. The stock has a market cap of $9.09 billion, a price-to-earnings ratio of 23.99, a PEG ratio of 1.80 and a beta of 0.87. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.02 and a current ratio of 1.75. Henry Schein, Inc. has a 52-week low of $60.01 and a 52-week high of $82.63. The business has a 50-day moving average price of $68.03 and a 200 day moving average price of $71.80.

Henry Schein (NASDAQ:HSIC) last issued its earnings results on Tuesday, May 7th. The company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.01 by $0.09. The business had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a return on equity of 13.51% and a net margin of 3.12%. Henry Schein’s revenue was up 3.7% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.21 EPS. Research analysts predict that Henry Schein, Inc. will post 5.16 EPS for the current fiscal year.

Analysts Set New Price Targets

A number of research analysts have recently commented on HSIC shares. Evercore ISI lowered their target price on Henry Schein from $75.00 to $72.00 and set an “in-line” rating for the company in a research note on Tuesday, July 9th. Baird R W raised shares of Henry Schein from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 22nd. Piper Sandler reissued an “overweight” rating and set a $86.00 price target on shares of Henry Schein in a research report on Friday, June 21st. Barrington Research reissued an “outperform” rating and set a $92.00 price objective on shares of Henry Schein in a research note on Friday, July 5th. Finally, UBS Group decreased their target price on shares of Henry Schein from $82.00 to $80.00 and set a “neutral” rating for the company in a research note on Wednesday, May 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating, six have given a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $81.67.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.